BlackRock Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $4.02M | Buy |
63,375
+12,037
| +23% | +$763K | ﹤0.01% | 1299 |
|
|
2016
Q3 | $3.27M | Sell |
51,338
-665
| -1% | -$42.3K | ﹤0.01% | 1313 |
|
|
2016
Q2 | $3.87M | Buy |
52,003
+10,246
| +25% | +$762K | ﹤0.01% | 1197 |
|
|
2016
Q1 | $2.79M | Sell |
41,757
-1,184
| -3% | -$79.1K | ﹤0.01% | 1340 |
|
|
2015
Q4 | $2.91M | Buy |
42,941
+2,744
| +7% | +$186K | ﹤0.01% | 1292 |
|
|
2015
Q3 | $2.15M | Sell |
40,197
-2,374
| -6% | -$127K | ﹤0.01% | 1445 |
|
|
2015
Q2 | $2.68M | Buy |
42,571
+5,979
| +16% | +$376K | ﹤0.01% | 1399 |
|
|
2015
Q1 | $1.76M | Sell |
36,592
-9,094
| -20% | -$438K | ﹤0.01% | 1529 |
|
|
2014
Q4 | $1.52M | Buy |
45,686
+24,810
| +119% | +$824K | ﹤0.01% | 1618 |
|
|
2014
Q3 | $612K | Sell |
20,876
-6,999
| -25% | -$205K | ﹤0.01% | 2059 |
|
|
2014
Q2 | $1.08M | Sell |
27,875
-10,777
| -28% | -$419K | ﹤0.01% | 1757 |
|
|
2014
Q1 | $1.62M | Sell |
38,652
-7,431
| -16% | -$312K | ﹤0.01% | 1699 |
|
|
2013
Q4 | $1.51M | Buy |
46,083
+34,718
| +305% | +$1.14M | ﹤0.01% | 1709 |
|
|
2013
Q3 | $307K | Buy |
11,365
+9,562
| +530% | +$258K | ﹤0.01% | 2358 |
|
|
2013
Q2 | $42K | Buy |
+1,803
| New | +$42K | ﹤0.01% | 2442 |
|